Dendritic cells (DCs) refer to a rare form of leukocytes. They have brought about their latest application for healing most cancer vaccinations as they may be uniquely powerful in their capacity to present antigens to T cells. Dendritic cell cancer vaccines which started out its adventure with ex-vivo scientific trials in murine fashions have now gone on to rephrasing the molecular mechanism of the immune device, enriching our immunological knowledge and empowering our capability to counteract the tumor growth.
Introduction Pediatrics Adults Provenge was the first DC vaccine which was brought into the market. So clearly it follows that is the market leader and is anticipated to remain so till the cease of the forecast period.
Some of the leading companies dominating the market include 3M Company, Activarti, Argos Therapeutics, Batavia Bioservices, Bellicum Pharmaceuticals, Creagene, DanDrit Biotech, DCPrime, Sanpower Corporation (Dendreon Corporation). Other players in the market include Elios Therapeutics. ImmunoCellular Therapeutics, Immunicum, Kiromic, Medigene, Merck & co, Northwest Biotherapeutics, Glaxo Smith Kline, ImmunoCellular Therapeutics, Tella Incorporation, and Vaxil BioTherapeutics.
Contact Info: Name: Mr. Abhishek Shukla Email: abhishek@marketdataforecast.com Organization: MarketDataForecast™ Address: 2nd Floor, Above ICICI Bank,B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
